We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCA
376
Harbour Capital Advisors
Virginia
$15.7K +$14.2K +289 New
BWP
377
Baldwin Wealth Partners
Massachusetts
$14K +$12.3K +250 New
MM
378
Midas Management
New York
$14K +$12.3K +250 New
BL
379
Balentine LLC
Georgia
$14K +$12.4K +251 New
PG
380
Patten Group
Tennessee
$14K +$12.4K +251 New
RA
381
Rational Advisors
New York
$14K +$12.8K +259 New
HDIM
382
Hanson & Doremus Investment Management
Vermont
$14K +$12.9K +262 New
SPIA
383
Steward Partners Investment Advisory
New York
$14K +$13K +263 New
ASN
384
Advisory Services Network
Georgia
$14K +$13.1K +265 New
FWM
385
Focused Wealth Management
New York
$13K +$11.7K +237 New
TSW
386
Thompson Siegel & Walmsley
Virginia
$11K +$9.75K +198 New
PCTC
387
Perkins Coie Trust Company
Washington
$11K +$9.85K +200 New
PCP
388
Proficio Capital Partners
Massachusetts
$10K +$9.26K +188 New
AOWM
389
Alpha Omega Wealth Management
Virginia
$9K +$7.98K +162 New
PSC
390
Prentiss Smith & Co
Vermont
$9K +$8.23K +167 New
CAW
391
Cornerstone Advisors (Washington)
Washington
$9K +$8.57K +174 New
PWM
392
Perigon Wealth Management
California
$8K +$7K +142 New
PMFA
393
Plante Moran Financial Advisors
Michigan
$8K +$7.68K +156 New
GI
394
Gradient Investments
Minnesota
$7K +$6.26K +127 New
CHC
395
City Holding Co
West Virginia
$7K +$6.75K +137 New
SNT
396
Security National Trust
West Virginia
$6K +$5.27K +107 New
WCBA
397
Weaver C. Barksdale & Associates
Tennessee
$6K +$5.32K +108 New
SQA
398
Simon Quick Advisors
New Jersey
$6K +$5.67K +115 New
VCM
399
Versant Capital Management
Arizona
$6K +$5.76K +117 New
QCG
400
Quadrant Capital Group
Ohio
$6K +$10K +203 New
14 15
16
17 18

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.